SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-037139
Filing Date
2024-04-29
Accepted
2024-04-29 16:01:30
Documents
17
Period of Report
2024-04-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0204784-8k_nkgen.htm   iXBRL 8-K 44304
2 FORM OF AMENDED AND RESTATED WARRANT ea020478401ex4-1_nkgen.htm EX-4.1 109199
3 LETTER AGREEMENT, DATED APRIL 28, 2024, BY AND BETWEEN THE COMPANY AND METEORA ea020478401ex10-1_nkgen.htm EX-10.1 27276
4 LETTER AGREEMENT, DATED APRIL 28, 2024, BY AND BETWEEN THE COMPANY AND SANDIA ea020478401ex10-2_nkgen.htm EX-10.2 26814
  Complete submission text file 0001213900-24-037139.txt   472253

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE nkgn-20240425.xsd EX-101.SCH 3882
6 XBRL DEFINITION FILE nkgn-20240425_def.xml EX-101.DEF 26779
7 XBRL LABEL FILE nkgn-20240425_lab.xml EX-101.LAB 37008
8 XBRL PRESENTATION FILE nkgn-20240425_pre.xml EX-101.PRE 25403
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0204784-8k_nkgen_htm.xml XML 6009
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40427 | Film No.: 24890467
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)